Connect with us

Legal & Regulation

DOJ-Commissioned University Study: Recreational Cannabis Legalization Has Very Minimal Effect on Crime Rates

Published

on

DOJ-Commissioned University Study: Recreational Cannabis Legalization Has Very Minimal Effect on Crime Rates

According to research studies sponsored by the federal government, legalization of cannabis for recreational purposes has not contributed to crime rates in the states of Washington and Colorado. The two were the first states to allow adult-use of marijuana in the U.S and hence became the focus of the study.

The Department of Justice commissioned the research, and its report was published today, October 8. The study was conducted by researchers from Stockton University, the University of Utah and Washington State University.

In the study, monthly crimes rates in Washington and Colorado as compiled by the FBI between 1999 and 2016 was compared to the monthly crime rate in the states that have not legalized medical and recreational cannabis use. The aim was to determine the impact of marijuana legalization on crime rates.

Surprisingly, there were no noteworthy long-term effects of legalizing marijuana for recreational purposes on the crime rates. Statistically, the difference in crime rates in Washington and Colorado compared to crime rates in stated that have illegalized marijuana use was very small. After the legalization of legal recreational marijuana in Washington, the state witnessed drop-in burglary rates. This shows that people who would have committed burglary often decide against committing the crime after getting high on weed. According to the study, the sale of recreational cannabis has had very minimal effects on crime if not none at all.

“Legalization of cannabis is still something new, and this is among the very first studies on that subject matter. By relying on the findings of the study, lawmakers will be in a position to understand and interpret the effects of marijuana legalization on crime,” said Dale W. Willits, professor of criminology and criminal justice.

According to Ruibin Lu, the lead author of the study, it is important to analyze the effects of the legalization of marijuana on crime for the first two years after its legalization. The researchers used the robust empirical methods to study these effects from the first two years of legalization of recreational cannabis.

Researchers in the study said that legalizing cannabis for leisure purposes has not significantly caused a rise in crime rates. The published report on the study is very straightforward and certain that the effects on crime rates are very minimal and easy to control.

Among the states that have legalized use of cannabis for recreational purposes are; Nevada, Oregon, Maine, Alaska, Michigan, California, Illinois and Vermont. Washington and Colorado were the first states to legalize recreational cannabis in the United States. Campaigns are underway to see it get legalized in every state in the United States.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.